Infographic: Consensus Recommendations on Biosimilars in Rheumatology

An international panel of healthcare stakeholders recently released consensus recommendations for the use of biosimilars to treat rheumatologic diseases. Learn more about what the panel had to say.

Related Content:

PracticeBusinessPolicy

Low Prices Fail to Boost Insulin Biosimilar Uptake in the UK

Clearing the Thicket: New Report Outlines Legislative Fixes to Boost Biosimilar Access

New Approvals Expand Access to Biosimilars for Ophthalmology, Bone, and Joint Conditions